Aurora Diagnostics, the leading independent specialized laboratory company focused on anatomic pathology, announced that it has sold its Greensboro, blood testing clinical laboratory to Dominion Diagnostics, effective December 31, 2014.
Terms of the transaction were not disclosed.
"We are pleased to complete this transaction, which allows us to focus our efforts and resources on our core business of anatomic pathology," said Daniel D. Crowley, CEO of Aurora Diagnostics. Aurora has entered into a laboratory services agreement with Dominion Diagnostics to perform clinical analysis for Aurora’s Greensboro pathology laboratory.
Dominion Diagnostics, headquartered in North Kingstown, R.I., is a leading, certified and accredited national medical laboratory that provides drug monitoring solutions and actionable clinical information to improve patient care and treatment outcomes in addiction medicine, chronic pain management and other healthcare specialties.
"This successful transaction with Aurora supports our ongoing commitment to advance treatment outcomes and improve patient care," says Bob Garvey, CEO of Dominion Diagnostics. "The launch of a new clinical pathology division in Greensboro will allow us to meet Aurora’s continued pathology needs and better address the needs of our clients and patients."
Beyond the expansion into clinical pathology made possible through the Greensboro laboratory acquisition, Dominion Diagnostics will initiate aggressive clinical research and development to launch new products and services that complement and expand upon its core business.